Sana Biotechnology Inc (NASDAQ:SANA) price on Thursday, March 20, fall -3.42% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $2.26.
A look at the stock’s price movement, the close in the last trading session was $2.34, moving within a range at $2.2 and $2.41. The beta value (5-Year monthly) was 1.637. Turning to its 52-week performance, $10.50 and $1.52 were the 52-week high and 52-week low respectively. Overall, SANA moved -26.86% over the past month.
Sana Biotechnology Inc’s market cap currently stands at around $508.56 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-16.
Turning to the stock’s technical picture we see that short term indicators suggest on average that SANA is a 100% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 2 recommend SANA as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
SANA’s current price about -13.71% and -23.98% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 39.62, while 7-day volatility ratio is 15.43% and 9.98% in the 30-day chart. Further, Sana Biotechnology Inc (SANA) has a beta value of 1.63, and an average true range (ATR) of 0.29. Analysts have given the company’s stock an average 52-week price target of $8, forecast between a low of $8 and high of $8. Looking at the price targets, the low is -253.98% off current price level while to achieve the yearly target high, price needs to move -253.98%. Nonetheless, investors will most likely welcome a -253.98% jump to $8 which is the analysts’ median price.
If we refocus on Sana Biotechnology Inc (NASDAQ:SANA), historical trading data shows that trading volumes averaged 3.67 over the past 10 days and 7.51 million over the past 3 months. The company’s latest data on shares outstanding shows there are 223.92 million shares.
The 44.38% of Sana Biotechnology Inc’s shares are in the hands of company insiders while institutional holders own 55.96% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 42.0 million on 2025-02-28, giving us a short ratio of 14.01. The data shows that as of 2025-02-28 short interest in Sana Biotechnology Inc (SANA) stood at 3888.9998 of shares outstanding, with shares short falling to 45.09 million registered in 2025-01-31. Current price change has pushed the stock 38.65% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the SANA stock continues to rise going into the next quarter.
